Skip to content

Optimizing Tobacco Dependence Treatment in the Emergency Department

Optimizing Tobacco Dependence Treatment in the Emergency Department

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02896400
Enrollment
1056
Registered
2016-09-12
Start date
2017-02-13
Completion date
2019-08-14
Last updated
2020-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Disorder

Brief summary

The investigators propose an innovative full-factorial design in a cohort of 1056 adult smokers in an urban emergency department (ED), to test the efficacy of four key intervention components: motivational interviewing, medication, quitline referral, and texting. At the trial's completion, a mixed-methods approach will be used to identify the components that were efficacious within the proposed cost constraint, along with feasibility and acceptability to providers and subjects. The investigators will then assemble an intervention that maximizes efficacy, given a cost-effectiveness constraint and findings from a qualitative analysis.

Detailed description

The investigators propose to optimize the identification and treatment of adult smokers seen in a hospital ED. To do this the Multiple Optimization Strategy (MOST) will be employed to develop a multicomponent intervention that will consist of some combination of the following: (1) a Brief Negotiation Interview (BNI, a variant of a motivational interview), delivered by a trained research assistant; (2) provision of 6 weeks of nicotine patches and gum to the research participant, with application of the first patch in the ED (NRT); (3) active referral to the Connecticut Smokers' Quitline (QL); and (4) enrollment in the SmokefreeText a short-messaging service (SMS) texting program for mobile phones (Text). Using MOST principles, the first phase of the study will use a 2x2x2x2 full-factorial design to identify the components most likely to be efficacious in combination. Although the factorial design requires the allocation of participants to 16 different combinations of the 4 components (Table 1), evaluation of each individual component is performed comparing all of those receiving a component to all of those not receiving a component, making this an efficient design. For instance, evaluation of the BNI component will compare those randomized to arms 1 through 8 to those in arms 9 to 16.The second phase will consist of designing and proposing a 2-arm randomized clinical trial comparing the efficacy of the multicomponent intervention package to usual care; this will be conducted in a future application. The specific aims of this proposed study are: Aim 1. To conduct a fully powered factorial randomized trial of 1056 adult smokers to test the efficacy of 4 key components of ED-initiated tobacco treatment: Brief Negotiated Interview (BNI), nicotine replacement therapy (NRT), Quitline referral (QL), and SmokeFreeText (Text). Aim 2. To identify the most efficacious components of our intervention, within fixed constraints of cost effectiveness and feasibility/acceptability to providers and subjects. Aim 3. To lay the groundwork for a future randomized trial testing the previously identified components, delivered as a package, against a control arm in a new cohort of adult ED smokers. Our associated hypotheses are: 1. At 3 months, at least 1 intervention component will yield a biochemically verified tobacco abstinence rate at least 5% greater than in the control condition. Carbon monoxide breath test will be used for biochemical verification. 2. At 3 months, at least 1 intervention will be cost-effective, using a societal perspective. 3. At 3 months, at least 1 intervention will be acceptable and feasible to providers and subjects.

Interventions

Brief motivational interview on smoking behavior

DRUGNicotine replacement therapy (NRT)

6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece.

OTHERCT Smokers Quitline (QL)

Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.

OTHERSmokefreeText (Text)

Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
National Institutes of Health (NIH)
CollaboratorNIH
Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * have smoked \>= 100 cigarettes lifetime * describe themselves as every or some day smokers * smoke at least 5 cigarettes/day * own a cellphone with texting capability * are able to give written informed consent

Exclusion criteria

* Inability to read or understand English * currently receiving formal tobacco dependence treatment * life-threatening or unstable medical, surgical, or psychobehavioral condition * unable to provide at least one collateral contact * live out-of-state * leaving the ED against medical advice * pregnant (self-report or urine testing), nursing, or trying to conceive.

Design outcomes

Primary

MeasureTime frameDescription
Tobacco Abstinence3 monthsAbstinence self reported and verified by exhaled carbon monoxide

Countries

United States

Participant flow

Participants by arm

ArmCount
NRT+QL+Text
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text) Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
BNI+QL+Text
Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
BNI+NRT+QL+Text
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
NRT+QL
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.
66
BNI+QL
Brief Negotiated Interview (BNI) Referral to CT Smokers Quitline (QL) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.
66
NRT Only
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece.
66
BNI+Text
Brief Negotiated Interview (BNI) Registration in SmokefreeText (Text) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
BNI+NRT+Text
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
NRT+Text
Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Registration in SmokefreeText (Text) Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
BNI+NRT
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece.
66
Control
Control arm, no intervention
66
BNI+NRT+QL
Brief Negotiated Interview (BNI) Nicotine replacement therapy (NRT) patches and gum, 6 weeks supply Referral to CT Smokers Quitline (QL) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior Nicotine replacement therapy (NRT): 6 weeks of nicotine replacement, patches and gum. First dose of each started in ED. Patches are 14mg or 21 mg. Gum is 2mg per piece. CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.
66
Text Only
Registration in SmokefreeText (Text) SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
QL+Text
Referral to CT Smokers Quitline (QL) Registration in SmokefreeText (Text) CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling. SmokefreeText (Text): Enrollment in a version of NCI's SmokefreeTxt, tailored for the study.
66
BNI Only
Brief Negotiated Interview (BNI) Brief Negotiated Interview (BNI): Brief motivational interview on smoking behavior
66
QL Only
Referral to CT Smokers Quitline (QL) CT Smokers Quitline (QL): Faxed referral to the CT Smokers Quitline for the subject. QL will then call subject to offer phone based counseling.
66
Total1,056

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003FG004FG005FG006FG007FG008FG009FG010FG011FG012FG013FG014FG015
1 Month Follow-upDeath0000000000000001
1 Month Follow-upLost to Follow-up7758965647553412
3 Month Follow-upDeath0000000000000110
3 Month Follow-upLost to Follow-up636111264365663532
Biochemical Verification at 3 MonthsLost to Follow-up1011013211001031
Biochemical Verification at 3 Monthsparticipant was not eligible for biochem45484640454848474452554152485256

Baseline characteristics

CharacteristicBNI+QL+TextTotalQL OnlyBNI OnlyQL+TextText OnlyBNI+NRT+QLControlBNI+NRTNRT+TextBNI+NRT+TextBNI+TextNRT OnlyBNI+QLNRT+QLNRT+QL+TextBNI+NRT+QL+Text
Age, Continuous41.33 years
STANDARD_DEVIATION 11.92
43.26 years
STANDARD_DEVIATION 12.12
43.21 years
STANDARD_DEVIATION 11.77
41.86 years
STANDARD_DEVIATION 10.42
42.36 years
STANDARD_DEVIATION 12.49
44.33 years
STANDARD_DEVIATION 12.23
43.18 years
STANDARD_DEVIATION 10.67
43.65 years
STANDARD_DEVIATION 14
44.30 years
STANDARD_DEVIATION 13.23
43.67 years
STANDARD_DEVIATION 12.6
43.77 years
STANDARD_DEVIATION 11.8
42.64 years
STANDARD_DEVIATION 12.42
42.26 years
STANDARD_DEVIATION 12.27
40.56 years
STANDARD_DEVIATION 11.97
43.73 years
STANDARD_DEVIATION 12.14
46.86 years
STANDARD_DEVIATION 10.72
44.36 years
STANDARD_DEVIATION 12.75
Cigarettes per Day (CPD)12.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day11.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day9.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day10.0 cigarettes per day
Ethnicity (NIH/OMB)
Hispanic or Latino
15 Participants231 Participants10 Participants14 Participants19 Participants13 Participants14 Participants13 Participants23 Participants14 Participants10 Participants19 Participants9 Participants15 Participants22 Participants14 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
51 Participants807 Participants56 Participants52 Participants45 Participants51 Participants49 Participants52 Participants43 Participants51 Participants55 Participants45 Participants55 Participants51 Participants43 Participants52 Participants56 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants18 Participants0 Participants0 Participants2 Participants2 Participants3 Participants1 Participants0 Participants1 Participants1 Participants2 Participants2 Participants0 Participants1 Participants0 Participants3 Participants
Heaviness of Smoking Index >=428 participants270 participants12 participants17 participants13 participants19 participants21 participants15 participants21 participants13 participants13 participants20 participants23 participants9 participants18 participants15 participants13 participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants15 Participants1 Participants0 Participants0 Participants0 Participants3 Participants1 Participants0 Participants1 Participants1 Participants1 Participants0 Participants2 Participants1 Participants2 Participants1 Participants
Race (NIH/OMB)
Asian
1 Participants3 Participants0 Participants1 Participants0 Participants0 Participants1 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
25 Participants401 Participants29 Participants19 Participants28 Participants29 Participants26 Participants27 Participants19 Participants23 Participants23 Participants23 Participants24 Participants26 Participants22 Participants24 Participants34 Participants
Race (NIH/OMB)
More than one race
5 Participants63 Participants2 Participants10 Participants5 Participants2 Participants0 Participants7 Participants5 Participants2 Participants5 Participants4 Participants6 Participants2 Participants5 Participants0 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants9 Participants0 Participants0 Participants1 Participants0 Participants1 Participants0 Participants1 Participants2 Participants1 Participants1 Participants0 Participants1 Participants0 Participants1 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants28 Participants3 Participants2 Participants4 Participants5 Participants0 Participants2 Participants1 Participants1 Participants1 Participants1 Participants0 Participants2 Participants3 Participants0 Participants2 Participants
Race (NIH/OMB)
White
33 Participants537 Participants31 Participants34 Participants28 Participants30 Participants35 Participants29 Participants40 Participants37 Participants35 Participants36 Participants36 Participants33 Participants35 Participants39 Participants26 Participants
Region of Enrollment
United States
66 Participants1056 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants66 Participants
Sex: Female, Male
Female
38 Participants536 Participants36 Participants31 Participants42 Participants33 Participants29 Participants35 Participants35 Participants41 Participants28 Participants34 Participants31 Participants28 Participants28 Participants32 Participants35 Participants
Sex: Female, Male
Male
28 Participants520 Participants30 Participants35 Participants24 Participants33 Participants37 Participants31 Participants31 Participants25 Participants38 Participants32 Participants35 Participants38 Participants38 Participants34 Participants31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
EG005
affected / at risk
EG006
affected / at risk
EG007
affected / at risk
EG008
affected / at risk
EG009
affected / at risk
EG010
affected / at risk
EG011
affected / at risk
EG012
affected / at risk
EG013
affected / at risk
EG014
affected / at risk
EG015
affected / at risk
deaths
Total, all-cause mortality
0 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 661 / 661 / 661 / 66
other
Total, other adverse events
0 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 66
serious
Total, serious adverse events
0 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 660 / 66

Outcome results

Primary

Tobacco Abstinence

Abstinence self reported and verified by exhaled carbon monoxide

Time frame: 3 months

Population: All participants eligible for 3 month follow-up (deceased participants excluded). Each intervention group was compared with all participants who did not receive that intervention. The comparison group therefore differed for each intervention: BNI=526; NRT=525; QL=527; Text = 526.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Brief Negotiated Interview (BNI)Tobacco Abstinence71 Participants
Brief Negotiated Interview (BNI) CONTROLTobacco Abstinence49 Participants
Nicotine Replacement Therapy (NRT)Tobacco Abstinence76 Participants
Nicotine Replacement Therapy (NRT) CONTROLTobacco Abstinence44 Participants
Quitline (QL)Tobacco Abstinence66 Participants
Quitline (QL) CONTROLTobacco Abstinence54 Participants
TextTobacco Abstinence61 Participants
Text CONTROLTobacco Abstinence59 Participants
Comparison: 8 arms including BNI (BNI only, BNI+NRT, BNI+QL, BNI+Text, BNI+NRT+QL, BNI+NRT+Text, BNI+QL+Text, BNI+NRT+QL+Text) compared to the 8 arms that do not include BNI (Control, NRT only, QL only, Text only, NRT+QL, NRT+Text, QL+Text, NRT+QL+Text)p-value: 0.0195% CI: [1.1, 2.8]Regression, Logistic
Comparison: 8 arms that include NRT (NRT only, BNI+NRT, NRT+QL, NRT+Text, BNI+NRT+QL, BNI+NRT+Text, NRT+QL+Text, BNI+NRT+QL+Text) compared to 8 arms that do not include NRT (Control, BNI only, QL only, Text only, BNI+QL, BNI+Text, QL+Text, BNI+QL+Text)p-value: 0.00195% CI: [1.3, 3.2]Regression, Logistic
Comparison: 8 arms including QL intervention (QL only, BNI+QL, NRT+QL, QL+Text, BNI+NRT+QL, BNI+QL+Text, NRT+QL+Text, BNI+NRT+QL+Text) compared to all 8 arms that did not include QL (Control, BNI only, NRT only, Text only, BNI+NRT, BNI+Text, NRT+Text, BNI+NRT+Text)p-value: 0.1495% CI: [0.9, 2.2]Regression, Logistic
Comparison: 8 arms including Text (Text only, BNI+Text, NRT+Text, QL+Text, BNI+NRT+Text, BNI+QL+Text, NRT+QL+Text, BNI+NRT+QL+Text) compared to 8 arms that do not include Text (Control, BNI only, NRT only, QL only, BNI+NRT, BNI+QL, NRT+QL, BNI+NRT+QL)p-value: 0.6495% CI: [0.7, 1.7]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026